DAPSONE
| Brand name | ACZONE |
|---|---|
| Active ingredient | DAPSONE |
| Strength | 7.5% |
| Dosage form | GEL |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | February 2016 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11273132 | November 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.